Birinapant

Birinapant has been studied in 2 papers since 2025: 1 observational study in people, 1 in animals; 1 in the past year. The newest paper, May 4, 2026: “Co-morbid biomarkers for sarcopenic obesity associated with gut microbiota metabolites: From burden to treatment”.

Intervention

2 papers study it1 findingUpdated

PubChemChEBI

See all 2 papers on birinapant

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country; 4 trials, none about aging, 3 with no results posted.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • 4 trials, none about aging, 3 with no results posted
  • Funders: American Cancer Society and 7 more
  • Humans1
  • Animals1

What did studies of birinapant find?

1

Studies of birinapant measured one outcome, glioblastoma.

Glioblastoma

downin mice1

1 study
  1. Birinapant prevents glioblastoma in mice (as an adjuvant after radiotherapy in PDX and immunocompetent mouse models of GBM).

    Animalsas an adjuvant after radiotherapy in PDX and immunocompetent mouse models of GBM

More on Glioblastoma

Trial sponsors

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months